New & Noteworthy

Submit New & Noteworthy

October 2019

Immunophenotyping Control Cells

Beckman Coulter Life Sciences

Beckman Coulter Life Sciences introduces its IVD ClearLLab Control Cells for leukemia and lymphoma immunophenotyping. The control cells have been designed to verify the performance of ClearLLab 10C panels of reagents and staining procedure. ClearLLab Control Cells are available in both normal and abnormal controls. The abnormal control has a blast-like population that is CD45 dim and expresses CD34, CD123, and CD117. They include assay values for the 27 markers currently available on the four ClearLLab10C panels.

Beckman Coulter Life Sciences

Click here to view product detail on Findit.

Current Issue

Enter our Sweepstakes now for your chance to win the following prizes:

Just answer the following quick question for your chance to win:

To continue, you must either login or register: